local_hospital

Pia Fond. Cardinale Giovanni Panico, Azienda Ospedaliera

Address
Via S. Pio X, 4, 73039 Tricase, Italy

Pia Fond. Cardinale Giovanni Panico - Neurological Research Center

Pia Fond. Cardinale Giovanni Panico, Azienda Ospedaliera is a specialized medical institution engaged in advanced neurological research, with particular emphasis on autonomic nervous system disorders and neurodegenerative conditions. The center demonstrates expertise in conducting complex Phase 3 clinical investigations that evaluate novel therapeutic interventions for challenging neurological manifestations.

  • Neurogenic orthostatic hypotension treatment and management
  • Multiple System Atrophy (MSA) research and clinical trials
  • Autonomic nervous system dysfunction therapies

The facility is actively involved in evaluating innovative pharmacological approaches for symptomatic neurogenic orthostatic hypotension in patients with Multiple System Atrophy. Their research protocols incorporate sophisticated methodologies including randomized withdrawal designs and comprehensive outcome assessments using validated tools such as the OHSA composite score, demonstrating their commitment to rigorous scientific evaluation of efficacy and durability in neurological therapeutics.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
9
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
2
Outperforms 36% of sites
public
Therapeutic diversity
2areas
Outperforms 41% of sites
groups
Sponsor diversity
2sponsors
Outperforms 37% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Pia Fond. Cardinale Giovanni Panico, Azienda Ospedaliera

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC trialFondazione GONO G.I.Phase IIINot Yet Recruiting

IMP list

lock Showing 1 of 9 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Ampreloxetine1Unknown2023-10-252023-10-25

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.